- Report
- June 2024
- 200 Pages
Global
From €7005EUR$7,950USD£6,106GBP
- Report
- June 2024
- 200 Pages
Global
From €7005EUR$7,950USD£6,106GBP
- Report
- February 2024
- 360 Pages
Global
From €7005EUR$7,950USD£6,106GBP
- Report
- February 2024
- 204 Pages
Global
From €7005EUR$7,950USD£6,106GBP
- Report
- March 2021
- 149 Pages
Global
From €6124EUR$6,950USD£5,338GBP
- Report
- November 2023
- 96 Pages
Asia Pacific
From €3040EUR$3,450USD£2,650GBP
- Report
- November 2023
- 99 Pages
Europe
From €3040EUR$3,450USD£2,650GBP
- Report
- November 2023
- 82 Pages
Africa, Middle East
From €3040EUR$3,450USD£2,650GBP
- Report
- November 2023
- 78 Pages
From €3040EUR$3,450USD£2,650GBP
- Report
- July 2024
- 109 Pages
North America
From €3040EUR$3,450USD£2,650GBP
- Report
- July 2024
- 97 Pages
Africa, Middle East
From €3040EUR$3,450USD£2,650GBP
- Report
- January 2024
- 206 Pages
Global
From €3921EUR$4,450USD£3,418GBP
- Report
- November 2023
- 87 Pages
North America
From €3040EUR$3,450USD£2,650GBP
- Report
- August 2023
- 188 Pages
Global
From €3921EUR$4,450USD£3,418GBP
- Report
- February 2024
- 113 Pages
Global
From €4186EUR$4,750USD£3,648GBP
- Report
- April 2023
- 112 Pages
Global
From €4186EUR$4,750USD£3,648GBP
- Report
- April 2023
- 111 Pages
Global
From €4186EUR$4,750USD£3,648GBP
- Report
- July 2024
- 150 Pages
Global
From €4186EUR$4,750USD£3,648GBP
- Report
- July 2024
- 110 Pages
Global
From €4186EUR$4,750USD£3,648GBP
- Report
- February 2024
- 132 Pages
Global
From €4186EUR$4,750USD£3,648GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more